1. Home
  2. VTRS vs JBL Comparison

VTRS vs JBL Comparison

Compare VTRS & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • JBL
  • Stock Information
  • Founded
  • VTRS 1961
  • JBL 1966
  • Country
  • VTRS United States
  • JBL United States
  • Employees
  • VTRS N/A
  • JBL N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • JBL Electrical Products
  • Sector
  • VTRS Health Care
  • JBL Technology
  • Exchange
  • VTRS Nasdaq
  • JBL Nasdaq
  • Market Cap
  • VTRS 15.6B
  • JBL 14.1B
  • IPO Year
  • VTRS N/A
  • JBL 1993
  • Fundamental
  • Price
  • VTRS $12.26
  • JBL $143.75
  • Analyst Decision
  • VTRS Hold
  • JBL Buy
  • Analyst Count
  • VTRS 3
  • JBL 7
  • Target Price
  • VTRS $13.67
  • JBL $145.17
  • AVG Volume (30 Days)
  • VTRS 7.1M
  • JBL 1.2M
  • Earning Date
  • VTRS 11-07-2024
  • JBL 12-18-2024
  • Dividend Yield
  • VTRS 3.92%
  • JBL 0.22%
  • EPS Growth
  • VTRS N/A
  • JBL 83.88
  • EPS
  • VTRS N/A
  • JBL 10.81
  • Revenue
  • VTRS $15,048,500,000.00
  • JBL $27,490,000,000.00
  • Revenue This Year
  • VTRS N/A
  • JBL N/A
  • Revenue Next Year
  • VTRS N/A
  • JBL $5.60
  • P/E Ratio
  • VTRS N/A
  • JBL $13.29
  • Revenue Growth
  • VTRS N/A
  • JBL N/A
  • 52 Week Low
  • VTRS $9.93
  • JBL $95.85
  • 52 Week High
  • VTRS $13.62
  • JBL $156.94
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 40.42
  • JBL 73.35
  • Support Level
  • VTRS $12.37
  • JBL $132.95
  • Resistance Level
  • VTRS $13.13
  • JBL $136.49
  • Average True Range (ATR)
  • VTRS 0.30
  • JBL 2.68
  • MACD
  • VTRS -0.11
  • JBL 0.23
  • Stochastic Oscillator
  • VTRS 1.00
  • JBL 65.43

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About JBL Jabil Inc.

Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.

Share on Social Networks: